Reactions to study indicating that hormone therapy improves cognitive function in people with Down's syndrome
Researchers have tested a gonadotropin-releasing hormone (GnRH) therapy in mouse models and in males (in a pilot clinical trial) with Down's syndrome. The results, published in the journal Science, suggest improved cognitive function.
0